NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Eamon P. Mulvaney, Helen M. Reid, Lucia Bialesova, Annie Bouchard, Dany Salvail, B. Therese Kinsella

Journal title: BMC Pulmonary Medicine

Journal number: 20/1

Journal publisher: BioMed Central

Published year: 2020

DOI identifier: 10.1186/s12890-020-1113-2

ISSN: 1471-2466